nifedipine has been researched along with oxazoles in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Obara, K; Usuki, T; Yabu, H | 1 |
| Hanson, RL; Isaacson, CM | 1 |
| Balazovjech, I; Dubai, G; Dvorak, I; Januszewicz, W; Krupa-Wojciechowska, B; Kubasik, A; Kuch-Wocial, A; Polak, G; Sadowski, Z; Simon, K; Stejfa, M; Szwed, H | 1 |
| Robles, NR | 1 |
| Caballero, E; Martín, E; Martín, ML; Medarde, M; Morán, A; Puebla, P; San Feliciano, A; San Román, L | 1 |
| Brinton, RD; Chen, Q; Kim, J; Monreal, AW; Oji, G; Patel, R; Sales, A | 1 |
| Eltit, JM; Hidalgo, J; Jaimovich, E; Liberona, JL | 1 |
| Aoyama, M; Chen, SR; Furuzono, S; Goto, T; Hotta, S; Imaizumi, Y; Ito, Y; Matsubara, T; Nakayama, S; Ohya, S; Shimokata, K; Wang, J; Yamada, A | 1 |
| Dakshinamurti, S; Gutsol, A; Halayko, AJ; Hinton, M; Mellow, L | 1 |
| Raymond, CR; Redman, SJ | 1 |
| Kuwahara, M | 1 |
| Blackman, BE; Cohen, I; Harris, HA; Leitman, DC; Mellon, SH; Pan, X; Pera, RA; Schonemann, MD; Tagliaferri, M; Weiner, RI; Zhang, L; Zogovic-Kapsalis, T | 1 |
| Casas, M; Escobar, M; Figueroa, R; Jaimovich, E; Jorquera, G; Molgó, J | 1 |
| Ajima, K; Kaidoh, M; Kawai, Y; Kimizuka, K; Maejima, D; Ohhashi, T | 1 |
| Ahmed, B; Keshari, M; Khalilullah, H; Khan, RA; Yusuf, M | 1 |
1 trial(s) available for nifedipine and oxazoles
| Article | Year |
|---|---|
Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine; Oxazoles; Rilmenidine; Treatment Outcome | 1998 |
14 other study(ies) available for nifedipine and oxazoles
| Article | Year |
|---|---|
Calcium and potassium channel regulation by protein phosphorylation in smooth muscle cells of guinea pig taenia coli.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Animals; Atropine; Calcium Channels; Carbachol; Colon; Guinea Pigs; In Vitro Techniques; Isoquinolines; Marine Toxins; Membrane Potentials; Models, Biological; Muscle, Smooth; Nifedipine; Oxazoles; Phorbol 12,13-Dibutyrate; Phorbol Esters; Phosphorylation; Piperazines; Potassium Channels; Protein Kinase C | 1992 |
Stimulation of insulin secretion from isolated rat islets by SaRI 59-801. Relation to cAMP concentration and Ca2+ uptake.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Calcium; Colforsin; Cyclic AMP; Diterpenes; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Isoxazoles; Male; Nifedipine; Oxazoles; Rats; Rats, Inbred Strains; Theophylline; Tolbutamide; Verapamil | 1985 |
[New central agents in the treatment of arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Clonidine; Diabetes Complications; Humans; Hypertension; Imidazoles; Nifedipine; Oxazoles; Renin-Angiotensin System; Reserpine; Rilmenidine; Risk Factors; Sympathetic Nervous System; Vasodilator Agents | 1999 |
Antihypertensive activity of substituted 2,3,8,8a-tetrahydro-7H-oxazolo[3,2-a]pyridinedicarboxylate enantiomers.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Evaluation; Heart Rate; Male; Nifedipine; Oxazoles; Pyridines; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Time Factors | 2000 |
Vasopressin-induced neurotrophism in cultured neurons of the cerebral cortex: dependency on calcium signaling and protein kinase C activity.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Arginine Vasopressin; Calcium Channels, L-Type; Calcium Signaling; Cell Differentiation; Cell Size; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Indoles; Macrocyclic Compounds; Maleimides; Memory; Nerve Growth Factors; Neurites; Neurons; Nifedipine; Oxazoles; Pregnancy; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Thionucleotides | 2000 |
Slow calcium signals after tetanic electrical stimulation in skeletal myotubes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Cells, Cultured; Electrophysiology; Enzyme Inhibitors; Estrenes; Image Processing, Computer-Assisted; Inositol 1,4,5-Trisphosphate Receptors; Kinetics; Macrocyclic Compounds; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Nifedipine; Oxazoles; Pyrrolidinones; Rats; Receptors, Cytoplasmic and Nuclear; Ryanodine; Signal Transduction; Time Factors; Transfection; Type C Phospholipases | 2004 |
Requirement of ryanodine receptors for pacemaker Ca2+ activity in ICC and HEK293 cells.
Topics: Anesthetics, Local; Animals; Biological Clocks; Boron Compounds; Caffeine; Calcium; Calcium Channel Blockers; Cell Line; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Fura-2; Humans; Ileum; Immunohistochemistry; Kinetics; Macrocyclic Compounds; Mice; Microscopy, Fluorescence; Muscle, Smooth; Nifedipine; Oxazoles; Proto-Oncogene Proteins c-kit; RNA, Messenger; Ryanodine; Ryanodine Receptor Calcium Release Channel; Tacrolimus; Tetracaine | 2004 |
Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Cells, Cultured; Disease Models, Animal; Heart Ventricles; Humans; Hypoxia; Infant, Newborn; Macrocyclic Compounds; Muscle Cells; Nifedipine; Organ Size; Oxazoles; Persistent Fetal Circulation Syndrome; Pulmonary Artery; Receptors, Thromboxane; Ryanodine; Swine; Vasoconstriction | 2006 |
Spatial segregation of neuronal calcium signals encodes different forms of LTP in rat hippocampus.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Signaling; Dendritic Spines; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Inositol 1,4,5-Trisphosphate Receptors; Kinetics; Long-Term Potentiation; Macrocyclic Compounds; Male; Neurons; Nifedipine; Oxazoles; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, N-Methyl-D-Aspartate; Ruthenium Red; Ryanodine Receptor Calcium Release Channel; Synaptic Transmission | 2006 |
Store-mediated calcium entry in pleural mesothelial cells.
Topics: Actins; Animals; Calcium; Cell Shape; Cells, Cultured; Cytochalasin D; Cytoskeleton; Depsipeptides; Epithelial Cells; Imidazoles; Marine Toxins; Microscopy, Confocal; Nifedipine; Oxazoles; Pleura; Rats; Thapsigargin | 2006 |
Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons.
Topics: Animals; Blotting, Western; Calcium; Calcium Signaling; Cell Differentiation; Cell Line; Embryonic Stem Cells; Estrogen Receptor beta; Humans; Immunohistochemistry; Immunoprecipitation; Mice; Neurons; Nifedipine; Nitriles; Oxazoles; Phosphorylation; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
IP(3)-dependent, post-tetanic calcium transients induced by electrostimulation of adult skeletal muscle fibers.
Topics: Animals; Calcium; Calcium Signaling; Electric Stimulation; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Mice; Mice, Inbred BALB C; Muscle Fibers, Skeletal; Nifedipine; Oxazoles; RNA, Messenger; Tetany; Troponin I | 2010 |
Sphingosine 1-phosphate (S1P) induces S1P2 receptor-dependent tonic contraction in murine iliac lymph vessels.
Topics: Animals; Aspirin; Biomechanical Phenomena; Calcium Signaling; Endothelium, Lymphatic; Estrenes; Lymphatic Vessels; Lysophospholipids; Macrocyclic Compounds; Male; Mice; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Oxazoles; Pressure; Pyrazoles; Pyridines; Pyrrolidinones; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine | 2013 |
Pharmacophore modeling, design, and synthesis of potent antihypertensives, oxazolo/thiazolo-[3,2-a]-pyrimidin-3(2H)-one, and 1,5-dihydroimidazo-[1,2-a]-pyrimidin-3(2H)-one derivatives: A pilot trial.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Drug Design; Female; Imidazoles; Male; Molecular Structure; Nifedipine; Oxazoles; Pilot Projects; Pyrimidines; Rats, Wistar; Structure-Activity Relationship; Thiazoles | 2020 |